Showing results (261-270 of 451) with videos related to

Sort By:
Pageof 46
Bioconjugate Chemistry|November 1, 1995
IL2-ricin fusion toxin is selectively cytotoxic in vitro to IL2 receptor-bearing tumor cellsA Frankel, E Tagge, J Chandler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 5, 1998
Heterotopic neurogenesis in a rat with cortical heterotopiaK S Lee, J L Collins, M J Anzivino, et al.
Bioconjugate Chemistry|January 1, 1996
Characterization of single site ricin toxin B chain mutantsA Frankel, E Tagge, J Chandler, et al.
Biochemistry|May 24, 2007
Mutational analysis of active site residues in the Staphylococcus aureus transpeptidase SrtABrenda A Frankel, Yan Tong, Matthew L Bentley, et al.
Cell Death Discovery|August 24, 2016
Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosisG G Jinesh, J R Molina, L Huang, et al.
Cancer Research|May 1, 1992
Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cellsS S Bacus, I Stancovski, E Huberman, et al.
Cancer Research|May 30, 1998
Activation of the ras-mitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell linesS E Patton, M L Martin, L L Nelsen, et al.
Leukemia|November 25, 2003
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemiasS Zhao, M Konopleva, M Cabreira-Hansen, et al.
Cancer Research|July 17, 2001
Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cellsI Braunstein, O Cohen-Barak, C Shachaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosisF J Xu, S Stack, C Boyer, et al.
Pageof 46